Heikkila-Laurila HP, Rajamaki MM. Idiopathic pulmonary fibrosis in West Highland white terriers. Vet Clin North Am Small Anim Pract. 2014;44:129-42.
Clercx C, Fastrès A, Roels E. Idiopathic pulmonary fibrosis in West Highland white terriers: an update. Vet J. 2018;242:53-8.
Roels E, Couvreur T, Farnir F, Clercx C, Verschakelen J, Bolen G. Comparison between sedation and general anesthesia for high resolution computed tomographic characterization of canine idiopathic pulmonary fibrosis in West Highland white terriers. Vet Radiol Ultrasound. 2017;58:284-94.
Thierry F, Handel I, Hammond G, King LG, Corcoran BM, Schwarz T. Further characterization of computed tomographic and clinical features for staging and prognosis of idiopathic pulmonary fibrosis in West Highland white terriers. Vet Radiol Ultrasound. 2017;58:381-8.
Johnson VS, Corcoran BM, Wotton PR, Schwarz T, Sullivan M. Thoracic high-resolution computed tomographic findings in dogs with canine idiopathic pulmonary fibrosis. J Small Anim Pract. 2005;46:381-8.
Syrja P, Heikkilä HP, Lilja-Maula L, Krafft E, Clercx C, Day MJ, et al. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. J Comp Pathol. 2013;149:303-13.
Crooks MG, Hart SP. Coagulation and anticoagulation in idiopathic pulmonary fibrosis. Eur Respir Rev. 2015;24:392-9.
Lin C, Borensztajn K, Spek CA. Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis. J Thromb Haemost. 2017;15:597-607.
Schuliga M, Grainge C, Westall G, Knight D. The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosis. Int J Biochem Cell Biol. 2018;97:108-17.
Jose RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69:190-2.
Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract. 2010;40:623-41.
Lilja-Maula LI, Laurila HP, Syrjä P, Lappalainen AK, Krafft E, Clercx C, et al. Long-term outcome and use of 6-minute walk test in West Highland white terriers with idiopathic pulmonary fibrosis. J Vet Intern Med. 2014;28:379-85.
Bauer N, Eralp O, Moritz A. Reference intervals and method optimization for variables reflecting hypocoagulatory and hypercoagulatory states in dogs using the STA compact automated analyzer. J Vet Diagn Investig. 2009;21:803-14.
Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19:32.
Barratt SL, Creamer A, Hayton C, Chaudhuri N. Idiopathic pulmonary fibrosis (IPF): an overview. J Clin Med. 2018;7:201.
Bargagli E, Madioni C, Bianchi N, Refini RM, Cappelli R, Rottoli P. Serum analysis of coagulation factors in IPF and NSIP. Inflammation. 2014;37:10-6.
Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, et al. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study. Thorax. 2014;69:207-15.
Jeffery U, Staber J, LeVine D. Using the laboratory to predict thrombosis in dogs: an achievable goal? Vet J. 2016;215:10-20.
Donahue SM, Brooks M, Otto CM. Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy. J Vet Emerg Crit Care. 2011;21:346-55.
McMichael MA, O'Brien M, Smith SA. Hypercoagulability in dogs with blastomycosis. J Vet Intern Med. 2015;29:499-504.
Vilar Saavedra P, Lara Garcia A, Zaldivar Lopez S, Couto G. Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability. Vet J. 2011;190:e78-83.
Lawrence J, Chang YM, Szladovits B, Davison LJ, Garden OA. Breed-specific hematological phenotypes in the dog: a natural resource for the genetic dissection of hematological parameters in a mammalian species. PLoS One. 2013;8:e81288.
Heikkila HP, Lappalainen AK, Day MJ, Clercx C, Rajamäki MM. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland white terriers with idiopathic pulmonary fibrosis. J Vet Intern Med. 2011;25:433-9.
Piguet PF, Vesin C. Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta 2 integrins. Int J Exp Pathol. 1994;75:321-8.
Ntolios P, Papanas N, Nena E, Boglou P, Koudelidis A, Tzouvelekis A, et al. Mean platelet volume as a surrogate marker for platelet activation in patients with idiopathic pulmonary fibrosis. Clin Appl Thromb Hemost. 2016;22:346-50.
Crooks MG, Fahim A, Naseem KM, Morice AH, Hart SP. Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor. PLoS One. 2014;9:e111347.
Fernandez IE, Eickelberg O. The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 2012;9:111-6.
Krafft E, Lybaert P, Roels E, Laurila HP, Rajamäki MM, Farnir F, et al. Transforming growth factor beta 1 activation, storage, and signaling pathways in idiopathic pulmonary fibrosis in dogs. J Vet Intern Med. 2014;28:1666-75.
Lilja-Maula L, Syrjä P, Laurila HP, Sutinen E, Rönty M, Koli K, et al. Comparative study of transforming growth factor-beta signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis. J Comp Pathol. 2014;150:399-407.
Roels E, Krafft E, Antoine N, Farnir F, Laurila HP, Holopainen S, et al. Evaluation of chemokines CXCL8 and CCL2, serotonin, and vascular endothelial growth factor serum concentrations in healthy dogs from seven breeds with variable predisposition for canine idiopathic pulmonary fibrosis. Res Vet Sci. 2015;101:57-62.
Nathan SD, Reffett T, Brown AW, Fischer CP, Shlobin OA, Ahmad S, et al. The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis. Chest. 2013;143:1692-8.
Swann JW, Sudunagunta S, Covey HL, English K, Hendricks A, Connolly DJ. Evaluation of red cell distribution width in dogs with pulmonary hypertension. J Vet Cardiol. 2014;16:227-35.
Mazzotta E, Guglielmini C, Menciotti G, Contiero B, Baron Toaldo M, Berlanda M, et al. Red blood cell distribution width, hematology, and serum biochemistry in dogs with echocardiographically estimated precapillary and postcapillary pulmonary arterial hypertension. J Vet Intern Med. 2016;30:1806-15.
McMichael MA, Smith SA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol. 2011;40:140-53.
Hanel RM, Chan DL, Conner B, Gauthier V, Holowaychuk M, Istvan S, et al. Systematic evaluation of evidence on veterinary viscoelastic testing part 4: definitions and data reporting. J Vet Emerg Crit Care. 2014;24:47-56.
Gommeren K, Desmas I, Garcia A, Bauer N, Moritz A, Roth J, et al. Inflammatory cytokine and C-reactive protein concentrations in dogs with systemic inflammatory response syndrome. J Vet Emerg Crit Care. 2018;28:9-19.
